跳至主要内容
临床试验/NCT05189275
NCT05189275已完成不适用

Cannabidiol and Focus Study (CBD-Focus)

University of Northern Colorado2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2022年1月10日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
100
试验地点
2
主要终点
Change in Natural Killer (NK) Cell Function

研究概览

简要总结

Cannabidiol (CBD), a non-psychoactive hemp derivative, is an attractive therapeutic target, and is most supported by the scientific community as an antiepileptic, anxiolytic, and antipsychotic. Additionally, CBD may cause alterations in aspects of health and fitness, fatigue, stress, calmness, quality of life, cognitive function, ability to maintain focus, sleep quantity, and sleep quality. Cannabidiol may be associated with alterations in inflammatory response in the human body, which has implications in both healthy and diseased populations. Natural killers cells (NKC) play a vital role in maintain your body's defenses and are an essential component of your immune system. In humans, NKC contain the highest concentrations of receptors associated with the endocannabinoid system and CBD. Human models have demonstrated that CBD use increases the percentage of NKC in peripheral blood. However, similar models found that CBD administration inhibits markers of NKC cytotoxic function, a beneficial cellular mechanism used to prevent malignant cell transformation and viral infection. The overarching goal of this investigation is to determine the effects of an 8-week CBD intervention on measures of fatigue, stress, calmness, quality of life, cognitive function, focus, health and fitness, and sleep quantity, and sleep quality. In addition, this study will explore a potential CBD mechanism of action with a focus on biomarkers of neural health, inflammation, liver health, kidney health, as well as NKC number and function.

详细描述

BACKGROUND: Cannabidiol (CBD), a non-psychoactive hemp derivative, is an attractive therapeutic target, and is most supported by the scientific community as an antiepileptic, anxiolytic, and antipsychotic. Additionally, CBD may cause alterations in aspects of health and fitness, fatigue, stress, calmness, quality of life, cognitive function, ability to maintain focus, sleep quantity, and sleep quality. Cannabidiol may be associated with alterations in inflammatory response in the human body, which has implications in both healthy and diseased populations. In humans, natural killer cells (NKC) contain the highest concentrations of receptors associated with the endocannabinoid system and CBD. Human models have demonstrated that CBD use increases the percentage of NKC in peripheral blood. However, similar models found that CBD administration inhibits markers of NKC cytotoxic function, a beneficial cellular mechanism used to prevent malignant cell transformation and viral infection. The overarching goal of this investigation is to determine the effects of an 8-week CBD intervention on measures of fatigue, stress, calmness, quality of life, cognitive function, focus, health and fitness, and sleep quantity, and sleep quality. In addition, this study will explore a potential CBD mechanism of action with a focus on biomarkers of neural health, inflammation, liver health, kidney health, as well as NKC number and function.

METHODS: In this double-blind, placebo-controlled, 4 arm clinical trial, male and female participants will undergo 2 pre intervention study visits and 3 post intervention study visits separated by an 8-week intervention period. Participants must be aged 18-50 years old, currently completing at least 150 minutes of moderate to vigorous physical activity per week, have a body mass index under 29.9, with no significant physical or mental health (without the presence of chronic depression or anxiety) conditions. Subjects may not have an allergy to soy. All study subjects must also be free of cannabis product use or regular high doses of antioxidants for the previous 8 weeks. Supplementation groups will be randomly assigned into groups consuming one of 4 beverages: 1) a beverage with 40 mg of CBD (CBD40, n=50), 2) a beverage with 20 mg of CBD (CBD20, n=50), 3) a beverage with 0 mg of CBD (CBD0, n=50) or 4) calorie-matched placebo (PLAC, n=50).

INTERVENTION DESCRIPTION: Participants will be instructed to consume one beverage per day following their last meal, 1-1.5h before bed. Four weeks of beverages will be provided at a time. These beverage deposits will include an in person check in at the midpoint of the study. Participants and researchers will be blinded to the intervention groups. All participants will be given a 4-week supply of beverages. Investigators will meet with participants weekly via zoom/phone call and to report any adverse side effects or changes in physical activity routine. All products will be provided by Ocean Spray. All products are hemp derived, within legal limits and have had their purity verified. Following the completion of data collection for all study participants, researchers will be unblinded to supplementation groups.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Currently completing at least 150 minutes of moderate to vigorous physical activity per week
  • Have a body mass index under 29.9
  • No significant physical or mental health (without the presence of chronic depression or anxiety) conditions
  • No presence or past diagnosis of eating disorders

排除标准

  • Subjects may not have an allergy to soy.
  • All study subjects must also be free of cannabis product use or regular high doses of antioxidants for the previous 8 weeks.
  • Participants receive a $200 Visa Gift Card after the last study visit is completed.

结局指标

主要结局

Change in Natural Killer (NK) Cell Function

时间窗: Just before the 8 Week Intervention and Immediately Following the 8 Week Intervention

NK Cell Cellular Function Assay using Flow Cytometry

Change in Fatigue Score

时间窗: Just before the 8 Week Intervention and Immediately Following the 8 Week Intervention

Piper Fatigue Questionnaire. A higher score suggests higher levels of fatigue.

Change in Sleep Assessment

时间窗: Just before the 8 Week Intervention and in the 7th Week of the 8 Week Intervention

Sleep Assessment (7 day). We will use Fitbits to track sleep.

Change in Physical Activity (steps per day)

时间窗: Just before the 8 Week Intervention and in the 7th Week of the 8 Week Intervention

Physical Activity Assessment (7 day). We will use Fitbits to track physical activity.

Change in General Anxiety Disorder Questionnaire Score

时间窗: Just before the 8 Week Intervention and Immediately Following the 8 Week Intervention

General Anxiety Disorder Questionnaire 7. A higher score suggests higher levels of anxiety.

Change in Psychological Wellbeing Scale Score

时间窗: Just before the 8 Week Intervention and Immediately Following the 8 Week Intervention

Psychological Wellbeing Questionnaire. A higher score suggests better wellbeing.

Change in Cognitive Function and Abilities Score

时间窗: Just before the 8 Week Intervention and Immediately Following the 8 Week Intervention

Patient-Reported Outcomes Measurement Information System (PROMIS) Cognitive Function Abilities - Short Form 8a. A higher score suggests higher cognitive ability.

Change in Natural Killer (NK) Cell Number

时间窗: Just before the 8 Week Intervention and Immediately Following the 8 Week Intervention

NK Cell Counts obtained on a flow cytometer.

Change in a Biomarker of Inflammation

时间窗: Just before the 8 Week Intervention and Immediately Following the 8 Week Intervention

Serum C-Reactive Protein

Change in Perceived Stress Scale Score

时间窗: Just before the 8 Week Intervention and Immediately Following the 8 Week Intervention

Perceived Stress Questionnaire. A higher score suggests higher perceived stress.

Change in Maximal Anaerobic Power

时间窗: Just before the 8 Week Intervention and Immediately Following the 8 Week Intervention

Wingate Power Test

Change in a Biomarker of Neural Health

时间窗: Just before the 8 Week Intervention and Immediately Following the 8 Week Intervention

Circulating Brain Derived Neurotropic Factor

Change in Quality of Life Questionnaire Score

时间窗: Just before the 8 Week Intervention and Immediately Following the 8 Week Intervention

Ferrans and Powers Quality of Life Index Questionnaire. A higher scores suggests higher quality of life.

Change in Sleep Questionnaire Score

时间窗: Just before the 8 Week Intervention and Immediately Following the 8 Week Intervention

Leeds Sleep Questionnaire. Lower scores generally suggest better sleep.

Change in Athlete Sickness and Illness Assessment Score

时间窗: Just before the 8 Week Intervention and Immediately Following the 8 Week Intervention

The Wisconsin Upper Respiratory Symptom Survey. A higher scores suggests more respiratory symptoms.

Change in Sustained Attention to Response Task (SART) Activity

时间窗: Just before the 8 Week Intervention and Immediately Following the 8 Week Intervention

Sustained Attention to Response Task (SART) Activity

Change in a Stress Biomarker

时间窗: Just before the 8 Week Intervention and Immediately Following the 8 Week Intervention

Serum Cortisol

Change in Liver Health Biomarker I

时间窗: Just before the 8 Week Intervention and Immediately Following the 8 Week Intervention

Serum Aspartate aminotransferase (AST)

Change in Liver Health Biomarker II

时间窗: Just before the 8 Week Intervention and Immediately Following the 8 Week Intervention

Serum Alanine aminotransferase (ALT)

Change In Cognitive Function Score

时间窗: Just before the 8 Week Intervention and Immediately Following the 8 Week Intervention

PROMIS Cognitive Function - Short Form 8a. A higher score suggests higher cognitive ability.

Change in Kidney Health Biomarker

时间窗: Just before the 8 Week Intervention and Immediately Following the 8 Week Intervention

Serum creatinine

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Laura Stewart

Professor

University of Northern Colorado

研究点 (2)

Loading locations...

相似试验